CDG Therapeutics, Inc. is a biotechnology company based in Elk Grove Village, IL, specializing in the development and commercialization of proprietary peptides derived from bacteria and green plants. These unique peptides have the remarkable ability to selectively enter cancer cells, leading to cell cycle arrest and eventual cell death.
With a focus on innovative science and technology, CDG Therapeutics is dedicated to advancing its platform pipeline through adult and pediatric phase I clinical trials. The company's vision, mission, and values drive its commitment to revolutionizing cancer treatment through groundbreaking research and development.
Generated from the website